Awards & Recognition
2026
TMC Netherlands BioBridge Program
VivArt-X was selected as one of 12 Dutch MedTech companies for the 2026 TMC Netherlands BioBridge Program, supporting expansion into the U.S. healthcare market.
€500K SBMC Innovation Project
VivArt-X and SBMC launched a €500,000 innovation project to advance the regenerative biomaterial platform towards medical application.
Brainport Young Business Award
VivArt-X was named winner of the Brainport Young Business Award 2026.
2025
Co-funded by the European Union: €3M Multidisciplinary Collaboration
VivArt-X joined a €3 million multidisciplinary project with MUMC+, TU/e and Maastricht University to accelerate towards clinical development.
Santiago WISE Award
CEO Dan Jing Wu was named one of five recipients of the 2025 Santiago WISE Award for female entrepreneurs in medical technology.
2024
NAE Young Engineer 2024
CEO Dan Jing Wu was selected as one of four Young Engineers of 2024 by the Netherlands Academy of Engineering.
Women of the Future Top 50
Dan Jing Wu was selected as one of the 50 Global Rising Stars in ESG by the Women of the Future Programme.
MT/Sprout Startup of the Year
VivArt-X was selected as one of 12 nominees for the MT/Sprout Startup of the Year Award 2024.
Termeer Transatlantic Connections Award
CEO Dan Jing Wu received the 2024 Henri Termeer Transatlantic Connections Award and joined the Class of 2024 Termeer Fellows.
2023
Academic Startup Competition
VivArt-X was selected as a Top 20 finalist in Techleap’s Academic Startup Competition.
Co-funded by the European Union: €1.4M OPZuid Project
VivArt-X, SBMC and TU/e started a €1.4 million project to accelerate the development of regenerative biomaterials for breast reconstruction.
Brabant40 Award
VivArt-X was selected as one of the Top 3 most promising startups in Brabant in the Brabant40 Award 2023.
SIR Subsidy
VivArt-X was awarded the SIR subsidy for innovative startups in Brabant to support the legal aspects of product development.
European Innovation Award
VivArt-X won both the Healthcare & Wellbeing category and the Overall ESDP Innovation Challenge, receiving €12,000 in prize money.
Gerard & Anton Award
VivArt-X received a Gerard & Anton Award as one of the most promising startups in the Brainport region.
MIT Feasibility Study
VivArt-X was awarded a MIT feasibility study grant to support technical development and market validation of its regenerative technology.
INNOVASIAN Award
CEO and Co-founder Dan Jing Wu won the 2023 INNOVASIAN Award at the Pan Asian Awards.
FD 50 Talents under 35
Co-founder Dan Jing Wu was named one of Het Financieele Dagblad’s 50 Talents under 35.
2022
MAXIS CSI Innovator Award
VivArt-X won first prize in the MAXIS CSI Innovator Award, shared with Angiolutions.
NWO Take-off
VivArt-X was awarded a NWO Take-off Phase 1 grant to investigate the feasibility of its synthetic extracellular matrix technology.
2021
LifeSciences@Work Venture Challenge
VivArt-X was awarded a NWO Take-off Phase 1 grant to investigate the feasibility of its synthetic extracellular matrix technology.